RG Discovery

Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry

Jun 15, 2026

The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise – enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist...

Cellmover and Red Glead Discovery are awarded 15 Million NOK Eurostars Grant

Jan 10, 2025

Prestigious Eurostars program awarded funding to Cellmover and Red Glead Discovery! The grant will support the development of Cellmover’s nanobody-based checkpoint inhibitor therapy against lung cancer. In addition, a macrocyclic peptide approach will be pursued in parallel. “RGD is perfectly...

Publication in Nature Communications showing that the neuroprotective activity of CDNF is mediated by its interaction with GRP78 protein

Sep 25, 2024

Red Glead Discovery is very happy to be a trusted drug discovery partner to Herantis Pharma Plc. Recently, this collaboration resulted in a joint publication in Nature Communications (Springer Nature Group) with additional key contributions from co-authors at EMBL,...